Cagrilintide: What It Is and How It's Being Studied for Weight Loss Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed Tirzepatide Dosage Chart: Where the Dose Sits in the FDA Schedule a PlexusDx Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet obesity gutsandgrowth Page 2 Cagrilintide, an amylin analogue, is a promising medication for weight loss by enhancing satiety, delaying gastric emptying, and suppressing appetite. In my patients, I have also seen increased